Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm

Adult nephrotic syndrome is primarily caused by membranous nephropathy (MN), with idiopathic membranous nephropathy (IMN) being a prominent subtype. The onset of phospholipase A2 receptor (PLA2R1)-associated IMN is critically linked to M-type PLA2R1 exposure, yet the mechanism underlying glomerular...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinxu Huang, Yaqing Huang, Xiaoling Zeng, Yuhong Zhang, Junneng Zhang, Qingchu Hong, Yongtiao Peng
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2438859
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841540134808322048
author Jinxu Huang
Yaqing Huang
Xiaoling Zeng
Yuhong Zhang
Junneng Zhang
Qingchu Hong
Yongtiao Peng
author_facet Jinxu Huang
Yaqing Huang
Xiaoling Zeng
Yuhong Zhang
Junneng Zhang
Qingchu Hong
Yongtiao Peng
author_sort Jinxu Huang
collection DOAJ
description Adult nephrotic syndrome is primarily caused by membranous nephropathy (MN), with idiopathic membranous nephropathy (IMN) being a prominent subtype. The onset of phospholipase A2 receptor (PLA2R1)-associated IMN is critically linked to M-type PLA2R1 exposure, yet the mechanism underlying glomerular injury remains unclear. In this study, membranous nephropathy datasets (GSE115857, GSE200828) were retrieved from GEO. Differential gene expression was analyzed using the ‘limma’ R package. WGCNA filtered PLA2R-related modules and intersected genes. LASSO regression, evaluated by ROC analysis, identified characteristic genes. Binomial logistic regression assessed their association with IMN. Validation was performed in the GSE133288 dataset. IHC and qRT-PCR detected characteristic gene expression in PLA2R-positive patients. This study identified elevated PLA2R expression in IMN patients among 117 DEGs. PPI analysis suggested enrichment in Golgi membranes, co-regulation, and glucocorticoid responsiveness, implicating the PPAR pathway by KEGG. WGCNA revealed a 440-gene brown module associated with IMN-PLA2R, with ECM1, SLC19A2, RASD1, FOSB, KDELR3, ZFP36, and ELF4 highlighted as diagnostic markers by ROC analysis. Clinical validation confirmed ECM1 upregulation increased IMN risk, while upregulation of SLC19A2, ZFP36, RASD1, and FOSB decreased it. ECM1 positively correlated with PLA2R, whereas SLC19A2, ZFP36, and FOSB negatively correlated. IHC analysis demonstrated consistent gene expression patterns in IMN tissues, with podocyte exposure to PLA2R-positive serum reducing viability and increasing apoptosis. Functional studies, prompted by RASD1 downregulation, revealed enhanced cell activity and reduced apoptosis upon RASD1 overexpression compared to the Serum + Ov-NC control. Collectively, this study identified diagnostic markers for PLA2R-related IMN, offering novel therapeutic targets for the treatment of IMN.
format Article
id doaj-art-91ba0d02fb8c4581944c71d2f5a2ad0e
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-91ba0d02fb8c4581944c71d2f5a2ad0e2025-01-14T06:03:24ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2024.2438859Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithmJinxu Huang0Yaqing Huang1Xiaoling Zeng2Yuhong Zhang3Junneng Zhang4Qingchu Hong5Yongtiao Peng6Department of Laboratory Medicine, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaDepartment of Nephrology, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaDepartment of Nephrology, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaDepartment of Nephrology, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaDepartment of Laboratory Medicine, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaDepartment of Laboratory Medicine, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaDepartment of Nephrology, Xiamen Key Laboratory of Precision Diagnosis and Treatment of Chronic Kidney Disease, The Fifth Hospital of Xiamen, Xiamen, Fujian, ChinaAdult nephrotic syndrome is primarily caused by membranous nephropathy (MN), with idiopathic membranous nephropathy (IMN) being a prominent subtype. The onset of phospholipase A2 receptor (PLA2R1)-associated IMN is critically linked to M-type PLA2R1 exposure, yet the mechanism underlying glomerular injury remains unclear. In this study, membranous nephropathy datasets (GSE115857, GSE200828) were retrieved from GEO. Differential gene expression was analyzed using the ‘limma’ R package. WGCNA filtered PLA2R-related modules and intersected genes. LASSO regression, evaluated by ROC analysis, identified characteristic genes. Binomial logistic regression assessed their association with IMN. Validation was performed in the GSE133288 dataset. IHC and qRT-PCR detected characteristic gene expression in PLA2R-positive patients. This study identified elevated PLA2R expression in IMN patients among 117 DEGs. PPI analysis suggested enrichment in Golgi membranes, co-regulation, and glucocorticoid responsiveness, implicating the PPAR pathway by KEGG. WGCNA revealed a 440-gene brown module associated with IMN-PLA2R, with ECM1, SLC19A2, RASD1, FOSB, KDELR3, ZFP36, and ELF4 highlighted as diagnostic markers by ROC analysis. Clinical validation confirmed ECM1 upregulation increased IMN risk, while upregulation of SLC19A2, ZFP36, RASD1, and FOSB decreased it. ECM1 positively correlated with PLA2R, whereas SLC19A2, ZFP36, and FOSB negatively correlated. IHC analysis demonstrated consistent gene expression patterns in IMN tissues, with podocyte exposure to PLA2R-positive serum reducing viability and increasing apoptosis. Functional studies, prompted by RASD1 downregulation, revealed enhanced cell activity and reduced apoptosis upon RASD1 overexpression compared to the Serum + Ov-NC control. Collectively, this study identified diagnostic markers for PLA2R-related IMN, offering novel therapeutic targets for the treatment of IMN.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2438859PLA2Ridiopathic membranous nephropathyWGCNALASSO
spellingShingle Jinxu Huang
Yaqing Huang
Xiaoling Zeng
Yuhong Zhang
Junneng Zhang
Qingchu Hong
Yongtiao Peng
Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
Renal Failure
PLA2R
idiopathic membranous nephropathy
WGCNA
LASSO
title Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
title_full Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
title_fullStr Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
title_full_unstemmed Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
title_short Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
title_sort screening potential diagnostic biomarkers for pla2r associated idiopathic membranous nephropathy by wgcna analysis and lasso algorithm
topic PLA2R
idiopathic membranous nephropathy
WGCNA
LASSO
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2438859
work_keys_str_mv AT jinxuhuang screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm
AT yaqinghuang screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm
AT xiaolingzeng screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm
AT yuhongzhang screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm
AT junnengzhang screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm
AT qingchuhong screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm
AT yongtiaopeng screeningpotentialdiagnosticbiomarkersforpla2rassociatedidiopathicmembranousnephropathybywgcnaanalysisandlassoalgorithm